{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:54:09Z","timestamp":1722992049194},"reference-count":9,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Health, Czech Republic","award":["NT\/11307-5"],"award-info":[{"award-number":["NT\/11307-5"]}]},{"name":"for Clinical and Experimental Medicine, Prague, Czech Republic","award":["00023001"],"award-info":[{"award-number":["00023001"]}]}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.ejim.2015.02.019","type":"journal-article","created":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T11:05:18Z","timestamp":1425639918000},"page":"367-368","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Association between polymorphism within the RYR2 receptor and development of statin-associated myalgia\/myopathy in the Czech population"],"prefix":"10.1016","volume":"26","author":[{"given":"Jaroslav A.","family":"Hubacek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Adamkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Hruba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Ceska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Vrablik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2015.02.019_bb0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.nmd.2013.09.011","article-title":"Statin myotoxicity: a review of genetic susceptibility factors","volume":"24","author":"Needham","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ejim.2015.02.019_bb0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejim.2015.01.002","article-title":"Risk identification and possible countermeasures for muscle adverse effects during statin therapy","volume":"26","author":"Magni","year":"2015","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2015.02.019_bb0015","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/FPC.0b013e328343dd7d","article-title":"Cerivastatin, genetic variants, and the risk of rhabdomyolysis","volume":"21","author":"Marciante","year":"2011","journal-title":"Pharmacogenet Genomics"},{"issue":"Suppl. 3","key":"10.1016\/j.ejim.2015.02.019_bb0020","doi-asserted-by":"crossref","first-page":"S327","DOI":"10.33549\/physiolres.932865","article-title":"Statin-associated myopathy: from genetic predisposition to clinical management","volume":"63","author":"Vrablik","year":"2014","journal-title":"Physiol Res"},{"key":"10.1016\/j.ejim.2015.02.019_bb0025","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00228-011-1125-1","article-title":"SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia","volume":"68","author":"Santos","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ejim.2015.02.019_bb0030","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/FPC.0b013e3283620c3b","article-title":"OATP1B1-related drug\u2013drug and drug\u2013gene interactions as potential risk factors for cerivastatin-induced rhabdomyolysis","volume":"23","author":"Tamraz","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.ejim.2015.02.019_bb0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/FPC.0000000000000018","article-title":"The SLCO1B1 c.521T>C polymorphism is associated with dose decrease or switching during statin therapy in the Rotterdam study","volume":"24","author":"de Keyser","year":"2014","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.ejim.2015.02.019_bb0040","article-title":"SLCO1B1 polymorphism is not associated with risk of statin induced myalgia\/myopathy in Czech population","author":"Hubacek","year":"2015","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.ejim.2015.02.019_bb0045","first-page":"1009","article-title":"Apolipoprotein E polymorphism is not associated with statin induced myopathy","volume":"2","author":"Hubacek","year":"2015","journal-title":"Austin J Cardiovasc Dis Atheroscler"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620515000709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620515000709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T15:46:37Z","timestamp":1651419997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620515000709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0953620515000709"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2015.02.019","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between polymorphism within the RYR2 receptor and development of statin-associated myalgia\/myopathy in the Czech population","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2015.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}